Page last updated: 2024-08-18

framycetin and Peritoneal Neoplasms

framycetin has been researched along with Peritoneal Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, P; Goodly, LJ; Turner, T; Wells, A	1

Other Studies

1 other study(ies) available for framycetin and Peritoneal Neoplasms

Article	Year
EGF receptor signaling enhances in vivo invasiveness of DU-145 human prostate carcinoma cells. Clinical & experimental metastasis, 1996, Volume: 14, Issue:4 Topics: Animals; Carcinoma; Cell Division; Cell Movement; Enzyme Inhibitors; ErbB Receptors; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neomycin; Neoplasm Invasiveness; Neoplasm Transplantation; Neoplasms, Experimental; Peritoneal Cavity; Peritoneal Neoplasms; Prostate; Prostatic Neoplasms; Signal Transduction; Tumor Cells, Cultured; Type C Phospholipases	1996

Article

Year

EGF receptor signaling enhances in vivo invasiveness of DU-145 human prostate carcinoma cells.

Clinical & experimental metastasis, 1996, Volume: 14, Issue:4

Topics: Animals; Carcinoma; Cell Division; Cell Movement; Enzyme Inhibitors; ErbB Receptors; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neomycin; Neoplasm Invasiveness; Neoplasm Transplantation; Neoplasms, Experimental; Peritoneal Cavity; Peritoneal Neoplasms; Prostate; Prostatic Neoplasms; Signal Transduction; Tumor Cells, Cultured; Type C Phospholipases

1996